Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €12.25 EUR
Change Today +0.493 / 4.19%
Volume 2.3K
GME On Other Exchanges
Symbol
Exchange
Xetra
As of 3:35 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

geratherm medical ag (GME) Snapshot

Open
€11.81
Previous Close
€11.76
Day High
€12.44
Day Low
€11.71
52 Week High
05/29/15 - €13.48
52 Week Low
08/6/14 - €6.88
Market Cap
60.7M
Average Volume 10 Days
5.8K
EPS TTM
€0.41
Shares Outstanding
4.9M
EX-Date
06/8/15
P/E TM
29.9x
Dividend
€0.25
Dividend Yield
2.04%
Current Stock Chart for GERATHERM MEDICAL AG (GME)

Related News

No related news articles were found.

geratherm medical ag (GME) Related Businessweek News

No Related Businessweek News Found

geratherm medical ag (GME) Details

Geratherm Medical AG, a medical technology company, engages in the healthcare diagnostic, respiratory, medical warning system, and cardio/stroke businesses in Europe, South America, Germany, the Middle East, the United States, and internationally. It operates through Healthcare Diagnostic, Warming Systems, Cardio/Stroke, and Respiratory segments. The Healthcare Diagnostic segment offers clinical thermometers; blood pressure monitors; and products for women comprising pregnancy tests, various ovulation tests, chlamydia tests, yeast infection test kits, and pH tests. The Warming Systems segment provides medical warming systems under the UniqueTemp and Unique Resc+ brand names to maintain body temperature during operations and in rescue situations; and normac IC, an incubatory system offers solutions for premature newborns with its MR diagnostic. The Cardio/Stroke segment offers stroke risk analyser products consists of SRAclinic for dectecting paroxysmal atrial fibrillation to prevent strokes. The Respiratory segment is involved in the development and manufacture of Spirostik, Spirostik Complete, and spiroergometer for pulmonary and cardiopulmonary function diagnostics. The company markets its products through pharmacies, hospitals, and clinics. It exports its products to approximately 60 countries. Geratherm Medical AG is headquartered in Geschwenda, Germany.

144 Employees
Last Reported Date: 04/30/15

geratherm medical ag (GME) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

geratherm medical ag (GME) Key Developments

Geratherm Medical AG Reports Earnings Results for the First Quarter of 2015

Geratherm Medical AG reported earnings results for the first quarter of 2015. For the quarter, the company reported sales revenues of EUR 5.4 million, up 39.1%. EBITDA was EUR 929,000, up 85.5%. EBT was EUR 719,000, up 107.8%. Profit from ordinary business activities was EUR 627,000, up 109%. Earnings after taxes was EUR 569,000, up 198.7%. Overall performance was EUR 5.6 million, up 40.6%.

Geratherm Medical AG Proposes Dividend for 2014; Announces Consolidated Earnings Results for the Year Ended 31 December 2014; Provides Earnings Guidance for the First Quarter of 2015

Geratherm Medical AG proposed a dividend of 25 cents per share for the year 2014 compared to 24 cents a year ago. The company announced consolidated earnings results for the year ended 31 December 2014. Sales were up by 11.2% to EUR 18.7 million. EBITDA was up by 98.1% to EUR 3,171,000. EBIT was up by 204.4% to EUR 2,415,000. Profit from ordinary activities was up by 75.2% to EUR 2,251,000. Profit attributable to shareholders was up by 26.1% to EUR 1,682,000. Earnings per share were 34 cents compared to 27 cents a year ago. The company's positive development is expected to continue in 2015. In the first quarter of 2015, the company anticipates significant double-digit growth in both sales and earnings.

Geratherm Medical AG to Report Fiscal Year 2014 Results on Apr 23, 2015

Geratherm Medical AG announced that they will report fiscal year 2014 results on Apr 23, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GME:GR €12.25 EUR +0.493

GME Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GME.
View Industry Companies
 

Industry Analysis

GME

Industry Average

Valuation GME Industry Range
Price/Earnings 29.7x
Price/Sales 3.0x
Price/Book 2.8x
Price/Cash Flow 21.3x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GERATHERM MEDICAL AG, please visit www.geratherm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.